| Bioactivity | LolCDE-IN-4 (Compound 1) is exhibits antibacterial efficacy against gram negative bacteria Escherichia coli (MIC of 0.25-32 µg/ml) and Haemophilus influenzae, through inhibition LolCDE complex and disruption of lipoproteins release from the inner membrane[1]. |
| CAS | 1859918-13-0 |
| Formula | C20H21N3O2 |
| Molar Mass | 335.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. McLeod SM, et al., Small-molecule inhibitors of gram-negative lipoprotein trafficking discovered by phenotypic screening. J Bacteriol. 2015 Mar;197(6):1075-82. |
LolCDE-IN-4
CAS: 1859918-13-0 F: C20H21N3O2 W: 335.40
LolCDE-IN-4 (Compound 1) is exhibits antibacterial efficacy against gram negative bacteria Escherichia coli (MIC of 0.25
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.